Outcomes of expectant management after betamethasone for hypertensive disorders of pregnancy

References

• Walker JJ. Pre-eclampsia. Lancet 2000;356:1260–5
   PubMed Web of Science ®Google Scholar
• Koonin LM, MacKay AP, Berg CJ, et al. Pregnancy-related mortality surveillance – United States, 1987–1990. MMWR CDC Surveill Summ 1997;46:17–36
   PubMedGoogle Scholar
• Gifford R, Cunningham G. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;183:S1–22
   PubMed Web of Science ®Google Scholar
• Yoder SR, Thornburg LL, Bisognano JD. Hypertension in pregnancy and women of childbearing age. Am J Med 2009;122:890–5
   PubMed Web of Science ®Google Scholar
• Haddad B, Sibai BM. Chronic hypertension in pregnancy. Ann Med 1999;31:246–52
   PubMed Web of Science ®Google Scholar
• Lisonkova S, Joseph KS. Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease. Am J Obstet Gynecol 2013;209:544.e1–12
   PubMed Web of Science ®Google Scholar
• Bombrys AE, Barton JR, Habli M, Sibai BM. Expectant management of severe preeclampsia at 27(0/7) to 33(6/7) weeks’ gestation: maternal and perinatal outcomes according to gestational age by weeks at onset of expectant management. Am J Perinatol 2009;26:441–6
   PubMed Web of Science ®Google Scholar
• Sibai BM. Evaluation and management of severe preeclampsia before 34 weeks’ gestation. Am J Obstet Gynecol 2011;205:191–8
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 97: fetal lung maturity. Obstet Gynecol 2008;112:717–26
   PubMedGoogle Scholar
• Haddad B, Deis S, Goffinet F, et al. Maternal and perinatal outcomes during expectant management of 239 severe preeclamptic women between 24 and 33 weeks’ gestation. Am J Obstet Gynecol 2004;190:1590–5; discussion 5–7
   PubMed Web of Science ®Google Scholar
• Amorim MM, Santos LC, Faundes A. Corticosteroid therapy for prevention of respiratory distress syndrome in severe preeclampsia. Am J Obstet Gynecol 1999;180:1283–8
   PubMed Web of Science ®Google Scholar
• Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006;(3):CD004454
   PubMedGoogle Scholar
• National Institutes of Health Consensus Development Panel. Antenatal corticosteroids revisited: repeat courses – National Institutes of Health Consensus Development Conference Statement, August 17–18, 2000. Obstet Gynecol 2001;98:144–50
   PubMed Web of Science ®Google Scholar
• American College of Obsetricians and Gynecologists. ACOG Practice Bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol 2002;99:159–67
   Google Scholar
• Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 2003;102:181–92
   PubMed Web of Science ®Google Scholar
• Barton JR, O’Brien JM, Bergauer NK, et al. Mild gestational hypertension remote from term: progression and outcome. Am J Obstet Gynecol 2001;184:979–83
   PubMed Web of Science ®Google Scholar
• Hauth JC, Ewell MG, Levine RJ, et al. Pregnancy outcomes in healthy nulliparas who developed hypertension. Calcium for Preeclampsia Prevention Study Group. Obstet Gynecol 2000;95:24–8
   PubMed Web of Science ®Google Scholar
• Knuist M, Bonsel GJ, Zondervan HA, Treffers PE. Intensification of fetal and maternal surveillance in pregnant women with hypertensive disorders. Int J Gynaecol Obstet 1998;61:127–33
   PubMed Web of Science ®Google Scholar
• Sibai BM, Hauth J, Caritis S, et al. Hypertensive disorders in twin versus singleton gestations. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol 2000;182:938–42
   PubMed Web of Science ®Google Scholar
• Buchbinder A, Sibai BM, Caritis S, et al. Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia. Am J Obstet Gynecol 2002;186:66–71
   PubMed Web of Science ®Google Scholar
• Barton JR, Stanziano GJ, Sibai BM. Monitored outpatient management of mild gestational hypertension remote from term. Am J Obstet Gynecol 1994;170:765–9
   PubMed Web of Science ®Google Scholar
• Barton JR, Istwan NB, Rhea D, et al. Cost-saving analysis of an outpatient management program for women with pregnancy-related hypertensive conditions. Dis Manag 2006;9:236–41
   PubMedGoogle Scholar
• American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol 2013;122:1122–31
   PubMed Web of Science ®Google Scholar
• Belghiti J, Kayem G, Tsatsaris V, et al. Benefits and risks of expectant management of severe preeclampsia at less than 26 weeks gestation: the impact of gestational age and severe fetal growth restriction. Am J Obstet Gynecol 2011;205:465.e1–6
   PubMed Web of Science ®Google Scholar
• Bombrys AE, Barton JR, Nowacki EA, et al. Expectant management of severe preeclampsia at less than 27 weeks’ gestation: maternal and perinatal outcomes according to gestational age by weeks at onset of expectant management. Am J Obstet Gynecol 2008;199:247.e1–6
   Web of Science ®Google Scholar
• Odendaal HJ, Pattinson RC, Bam R, et al. Aggressive or expectant management for patients with severe preeclampsia between 28–34 weeks’ gestation: a randomized controlled trial. Obstet Gynecol 1990;76:1070–5
   PubMed Web of Science ®Google Scholar
• Sibai BM, Mercer BM, Schiff E, Friedman SA. Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks’ gestation: a randomized controlled trial. Am J Obstet Gynecol 1994;171:818–22
   PubMed Web of Science ®Google Scholar
• Rath W, Faridi A, Dudenhausen JW. HELLP syndrome. J Perinat Med 2000;28:249–60
   PubMed Web of Science ®Google Scholar
• Mansueto G, Mistretta V, Angelozzi D, et al. HELLP syndrome. A retrospective study of 36 patients. Recenti Prog Med 2007;98:166–8
   Google Scholar
• Sibai BM, Ramadan MK, Usta I, et al. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol 1993;169:1000–6
   PubMed Web of Science ®Google Scholar
• Gasem T, Al Jama FE, Burshaid S, et al. Maternal and fetal outcome of pregnancy complicated by HELLP syndrome. J Matern Fetal Neonatal Med 2009;22:1140–3
   PubMed Web of Science ®Google Scholar
• Van Pampus MG, Wolf H, Westenberg SM, et al. Maternal and perinatal outcome after expectant management of the HELLP syndrome compared with pre-eclampsia without HELLP syndrome. Eur J Obstet Gynecol Reprod Biol 1998;76:31–6
   PubMed Web of Science ®Google Scholar
• Van Runnard Heimel PJ, Huisjes AJ, Franx A, et al. A randomised placebo-controlled trial of prolonged prednisolone administration to patients with HELLP syndrome remote from term. Eur J Obstet Gynecol Reprod Biol 2006;128:187–93
   PubMed Web of Science ®Google Scholar
• MacKenna J, Dover NL, Brame RG. Preeclampsia associated with hemolysis, elevated liver enzymes, and low platelets – an obstetric emergency? Obstet Gynecol 1983;62:751–4
   PubMed Web of Science ®Google Scholar
• Heyborne KD, Burke MS, Porreco RP. Prolongation of premature gestation in women with hemolysis, elevated liver enzymes and low platelets. A report of five cases. J Reprod Med 1990;35:53–7
   PubMedGoogle Scholar
• Visser W, Wallenburg HC. Temporising management of severe pre-eclampsia with and without the HELLP syndrome. Br J Obstet Gynaecol 1995;102:111–17
   PubMedGoogle Scholar
• Heller CS, Elliott JP. High-order multiple pregnancies complicated by HELLP syndrome. A report of four cases with corticosteroid therapy to prolong gestation. J Reprod Med 1997;42:743–6
   PubMed Web of Science ®Google Scholar
• Van Pampus MG, Wolf H, Ilsen A, Treffers PE. Maternal outcome following temporizing management of the (H)ELLP syndrome. Hypertens Pregnancy 2000;19:211–20
   PubMed Web of Science ®Google Scholar
• Abramovici D, Friedman SA, Mercer BM, et al. Neonatal outcome in severe preeclampsia at 24 to 36 weeks’ gestation: does the HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome matter? Am J Obstet Gynecol 1999;180:221–5
   PubMed Web of Science ®Google Scholar
• Magee LA, Yong PJ, Espinosa V, et al. Expectant management of severe preeclampsia remote from term: a structured systematic review. Hypertens Pregnancy 2009;28:312–47
   PubMed Web of Science ®Google Scholar
• Woudstra DM, Chandra S, Hofmeyr GJ, Dowswell T. Corticosteroids for HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome in pregnancy. Cochrane Database Syst Rev 2010:CD008148
   PubMedGoogle Scholar
• Samuel A, Lin C, Parviainen K, Jeyabalan A. Expectant management of preeclampsia superimposed on chronic hypertension. J Matern Fetal Neonat Med 2011;24:907–11
   PubMed Web of Science ®Google Scholar
• Garite TJ, Kurtzman J, Maurel K, Clark R. Impact of a ‘rescue course’ of antenatal corticosteroids: a multicenter randomized placebo-controlled trial. Am J Obstet Gynecol 2009;200:248.e1–9
   PubMed Web of Science ®Google Scholar